BRIEF-First Tracks Biotherapeutics Announces Positive Top-Line Results For ANB033 In Gluten-Challenge Study In Celiac Disease

1

Oct 12 (Reuters) – First Tracks Biotherapeutics Inc : * FIRST TRACKS BIOTHERAPEUTICS ANNOUNCES POSITIVE TOP-LINE RESULTS FOR ANB033 IN GLUTEN-CHALLENGE STUDY IN CELIAC DISEASE * FIRST TRACKS

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)